FDA Approves Pfizer-BioNTech Vaccine For Children Of Age 5 to 11

The US FDA Authorizes The Pfizer-BioNTech Vaccine For Young Kids As anticipated, the US FDA (Food & Drug Administration) approved EUA (Emergency Use Authorization) for the Covid-19 vaccine co-produced by BioNTech & Pfizer for children of age group of 5-11. One-third of the dosage administered to adults will be given to children. There are around […] The post FDA Approves Pfizer-BioNTech Vaccine For Children Of Age 5 to 11 appeared first on BioTecNika.
http://dlvr.it/SBfmQL

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment